{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:53:12Z","timestamp":1790009592815,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:00:00Z","timestamp":1674950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010891","name":"Guizhou Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejogrb.2023.01.012","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T12:16:19Z","timestamp":1673612179000},"page":"43-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Recombinant-luteinzing hormone supplementation in women during IVF\/ICSI cycles with GNRH-antagonist protocol: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"283","author":[{"given":"Lan","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-2435","authenticated-orcid":false,"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejogrb.2023.01.012_b0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.301.1.95","article-title":"Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix","volume":"301","author":"Broqua","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.01.012_b0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.01.012_b0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.01.012_b0020","first-page":"113","article-title":"Influence of GnRH antagonist in reproductive women on in vitro fertilization and embryo transfer in fresh cycles","volume":"10","author":"Xu","year":"2019","journal-title":"Biomed Rep"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.01.012_b0025","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/humrep\/deg407","article-title":"GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles","volume":"18","author":"Lindheim","year":"2003","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.01.012_b0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00001703-200206000-00004","article-title":"Is luteinizing hormone needed for optimal ovulation induction?","volume":"14","author":"Balasch","year":"2002","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.01.012_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.830567","article-title":"Low Endogenous LH on the COS Initiation Day of a GnRH-Agonist Regimen Increases the Risk of Early Pregnancy Loss and Adverse ART Outcomes","volume":"13","author":"Luo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.01.012_b0040","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.fertnstert.2010.10.021","article-title":"Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis","volume":"95","author":"Bosch","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.01.012_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2012.01.130","article-title":"The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis","volume":"97","author":"Hill","year":"2012","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.01.012_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/09513599209015549","article-title":"Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR","volume":"6","author":"Broekmans","year":"1992","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.01.012_b0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.rbmo.2011.03.023","article-title":"Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective","volume":"23","author":"Wong","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2023.01.012_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1477-7827-12-109","article-title":"Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization\/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis","volume":"12","author":"Xiong","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.01.012_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1472-6483(10)60758-4","article-title":"Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis","volume":"14","author":"Baruffi","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2023.01.012_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-021-00759-4","article-title":"Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials","author":"Conforti","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2023.01.012_b0075","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","author":"Alessandro","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2023.01.012_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2023.01.012_b0085","unstructured":"University M. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. 2015:developed by Evidence Prime, In."},{"key":"10.1016\/j.ejogrb.2023.01.012_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.01.012_b0095","doi-asserted-by":"crossref","unstructured":"Borenstein M. Introduction to Meta-Analysis. 2009.","DOI":"10.1002\/9780470743386"},{"issue":"16","key":"10.1016\/j.ejogrb.2023.01.012_b0100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJM200010193431614","article-title":"Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency","volume":"343","author":"Barnes","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.ejogrb.2023.01.012_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1439-0531.2008.01142.x","article-title":"Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women","volume":"43","author":"Mihm","year":"2008","journal-title":"Reprod Domest Anim"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.01.012_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000509162","article-title":"LH supplementation in ovarian stimulation for IVF: The individual, LH deficient, patient perspective","volume":"85","author":"Kol","year":"2020","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.01.012_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2003.11.040","article-title":"Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer","volume":"82","author":"Merviel","year":"2004","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.01.012_b0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","volume":"76","author":"Westergaard","year":"2001","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.01.012_b0125","first-page":"90","article-title":"Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?","volume":"8","author":"Ramachandran","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.01.012_b0130","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/mmr.2015.3904","article-title":"Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing","volume":"12","author":"Gizzo","year":"2015","journal-title":"Mol Med Rep"}],"updated-by":[{"DOI":"10.1016\/j.ejogrb.2024.11.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:59:42Z","timestamp":1759557582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":26,"alternative-id":["S0301211523000209"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.01.012","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejogrb.2024.11.012","asserted-by":"object"}]},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant-luteinzing hormone supplementation in women during IVF\/ICSI cycles with GNRH-antagonist protocol: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}